Abstract Advances in cancer immunology have increased the use of immune checkpoint inhibitors in clinical practice. however not all patients respond. and treatment can have severe side-effects. Blood-based immunological biomarkers are an attractive method for predicting which patients will respond to therapy. https://herbsdailyes.shop/product-category/signs/